Passage Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Passage Bio and other ETFs, options, and stocks.About PASG
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options.
CEOWilliam Chou
CEOWilliam Chou
Employees60
Employees60
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2017
Founded2017
Employees60
Employees60
PASG Key Statistics
Market cap46.49M
Market cap46.49M
Price-Earnings ratio-0.99
Price-Earnings ratio-0.99
Dividend yield—
Dividend yield—
Average volume127.60K
Average volume127.60K
High today$15.57
High today$15.57
Low today$14.55
Low today$14.55
Open price$14.56
Open price$14.56
Volume9.34K
Volume9.34K
52 Week high$20.00
52 Week high$20.00
52 Week low$5.12
52 Week low$5.12
Stock Snapshot
With a market cap of 46.49M, Passage Bio(PASG) trades at $14.90. The stock has a price-to-earnings ratio of -0.99.
During the trading session on 2026-01-14, Passage Bio(PASG) shares reached a daily high of $15.57 and a low of $14.55. At a current price of $14.90, the stock is +2.4% higher than the low and still -4.3% under the high.
Trading activity shows a volume of 9.34K, compared to an average daily volume of 127.6K.
Over the past 52 weeks, Passage Bio(PASG) stock has traded between a high of $20.00 and a low of $5.12.
Over the past 52 weeks, Passage Bio(PASG) stock has traded between a high of $20.00 and a low of $5.12.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own PASG. This list is generated using Robinhood data, and it’s not a recommendation.